In conclusion, the three ERs have distinct effects on prostate cancer, wherein ERβ and GPER1 exert tumor growth-suppressive effects (Table 1; Figure 6), and ERα, ERβ2, and ERβ5 exert tumor growth-promoting effects. Here, GPER1 is linked to prostate carcinoma.